AJMC August 10, 2024
Medicare Advantage beneficiaries with chronic obstructive pulmonary disease (COPD) who were invited to enroll in a program that reduced inhaler costs and provided medication management had higher inhaler adherence; however, there was no significant impact on exacerbations or overall health care spending.
Medicare Advantage beneficiaries with chronic obstructive pulmonary disease (COPD) who received an invitation to enroll in a program that reduced maintenance inhaler cost sharing and provided medication management had higher inhaler adherence, according to a study published in JAMA Internal Medicine.1
The researchers noted that improper use and cost-related nonadherence prevent patients with COPD from successfully using maintenance inhalers, which reduces the frequency and severity of exacerbations. More specifically, about 1 in 3 Medicare patients using inhalers reported...
Today's Sponsors
Today's Sponsor